FIELD: biotechnologies.
SUBSTANCE: invention relates to biotechnology and virology. Invention describes method for prediction of early reduction of viral load in human infected by hepatitis C virus (HCV) in response to interferon-excluding treatment, method for selection of interferon-excluding treatment duration, and method for prediction of HCV infected subject's response to interferon-excluding treatment. These methods involve detection of nucleotide in sample taken from subject, located in single-nucleotide polymorphism rs12979860 position, and interpretation of obtained results based on availability of alleles C or T in this position.
EFFECT: presented group of inventions can be applied in medicine.
15 cl, 2 dwg, 3 tbl, 1 ex
